The Roles of Lipoprotein in Psoriasis

Area of Science:

• Dermatology
• Cardiology
• Metabolic Diseases

Background:

• Epidemiological data link psoriasis to increased cardiovascular disease (CVD) risk.
• Psoriasis patients exhibit a higher adjusted relative risk for myocardial infarction.
• The CVD risk from severe psoriasis may rival that of diabetes mellitus.

Purpose of the Study:

• To explore the relationship between hyperlipidemia and psoriasis.
• To investigate potential novel treatment strategies for psoriasis by understanding its connection to lipid metabolism.

Main Methods:

• Review of existing epidemiological data and studies on low-density lipoprotein (LDL) in atherogenesis.
• Analysis of mechanisms by which oxidized LDL (ox-LDL) contributes to endothelial dysfunction and inflammation.
• Examination of vascular changes in psoriasis and their potential role in ox-LDL leakage.

Main Results:

• Low-density lipoprotein (LDL) is critical in atherogenesis, involving macrophage and lipoprotein accumulation in vessel walls.
• Oxidized LDL (ox-LDL) promotes the expression of adhesion molecules (ICAM-1, VVCAM-1) on endothelial cells.
• Psoriasis features dermal vascular abnormalities, potentially leading to ox-LDL leakage and subsequent inflammation.

Conclusions:

• The interplay between hyperlipidemia and psoriasis warrants further investigation.
• Understanding this relationship may offer novel therapeutic avenues for psoriasis management.
• Targeting lipid metabolism could be a promising strategy for treating psoriasis.